Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)

Autor: Freyer, Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Cancers; Volume 14; Issue 1; Pages: 29
ISSN: 2072-6694
DOI: 10.3390/cancers14010029
Popis: This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinical activity. Spring 2020 activities were compared to winter 2019–2020. Results showed a decrease of activity of 9% for treatment dispensations, 17% for multidisciplinary team meetings, 20% for head and neck and thoracic surgeries, and 58% for new patient enrolment in clinical trials. Characteristics of patients treated for solid cancer and hospitalized for COVID-19 during spring 2020 were collected in a retrospective study. Mortality was attributed to COVID-19 for half of the cases, 82% being patients above 70 and 73% being stage IV. This is in concordance with current findings concluding that the risk of developing severe or critical symptoms of COVID-19 is correlated with factors co-occurring in cancer patients and not to the cancer condition per se. While a number of routines and treatment regimens were changed, there was no major decline in numbers of treatments conducted at the IC-HCL during the first wave of the COVID-19 pandemic that hit France between March and May 2020, except for clinical trials and some surgery activities.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje